Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Pathological Complete Response of Rectal Cancer to Neoadjuvant Chemoradiotherapy With MR Radiomics Method

NCT03238885 is registered in ClinicalTrials.gov with Sun Ying-Shi as lead sponsor.

NCT NCT03238885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03238885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Pathological Complete Response of Rectal Cancer to Neoadjuvant Chemoradiotherapy With MR Radiomics Method
Lead sponsor
Sun Ying-Shi
Phase
Observational
Overall status
Completed
Start date
March 1, 2013
Completion date
January 21, 2019
Enrollment
538 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced rectal cancer